Additionally, we noticed that the 6-month administration of SGLT2 inhibitor dapagliflosin was associated with NYHA HF class improvement and favorable changes in LVESV, LVEF, LVMMI, and diastolic function parameters, which corresponded to a trend of decrease in NT-proBNP and the opposite dynamic in serum levels of adropin. Here, SLC5A2 is linked to hydrops fetalis.